Chimeric RNA Methods and Protocols /
| Autor Corporativo: | |
|---|---|
| Otros Autores: | , |
| Sumario: | XII, 262 p. 56 illus., 52 illus. in color. text |
| Lenguaje: | inglés |
| Publicado: |
New York, NY :
Springer US : Imprint: Humana,
2020.
|
| Edición: | 1st ed. 2020. |
| Colección: | Methods in Molecular Biology,
2079 |
| Materias: | |
| Acceso en línea: | https://doi.org/10.1007/978-1-4939-9904-0 |
| Formato: | Electrónico Libro |
Tabla de Contenidos:
- Prediction, Characterization, and In Silico Validation of Chimeric RNAs
- Identification of Fusion Transcripts from Unaligned RNA-Seq Reads Using ChimeRScope
- Identification of Chimeric RNAs Using RNA-Seq Reads and Protein-Protein Interactions of Translated Chimeras
- Gene Fusion Discovery with INTEGRATE
- Case Study: Systematic Detection and Prioritization of Gene Fusions in Cancer by RNA-Seq: A DIY Toolkit
- Detection and Measurement of Chimeric RNAs by RT-PCR
- Detection of Group II Intron-Generated Chimeric mRNAs in Bacterial Cells
- RNase Protection Assay
- Validation of Chimeric Fusion Peptides Using Proteomics Data
- NanoString nCounter Technology: High-Throughput RNA Validation
- Knockdown of Chimeric RNA by RNAi
- Overexpression of Chimeric RNA by Retroviral Transduction
- Separation of Nuclear and Cytoplasmic Fractions for Chimeric RNA Characterization
- Confirmation of Transcriptional Read-Through Events byRT-PCR
- Validating Gene Fusion as the Source of Chimeric RNAs
- Chimeric RNA and Exosomes-Based Liquid Biopsy
- SMaRT for Therapeutic Purposes
- Case Study: Landscape of Chimeric RNAs in Bladder Cancer
- Case Study: The Recurrent Fusion RNA DUS4L-BCAP29 in Non-Cancer Human Tissues and Cells.